Home
>
Gennex Laboratories Ltd Financials

Gennex Laboratories Ltd Financial Statement

Gennex Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

(Rs. CR)	Dec 2023	Sep 2023	Jun 2023
Revenue	19.32	14.3	14.18
Operating Expense	15.64	10.27	10.23
Net Profit	2.64	2.66	2.57
Net Profit Margin	13.66	18.6	18.12
Earning Per Share	0.15	0.15	0.15
EBIDTA	3.68	4.03	3.94
Effective Tax Rate	14.13	22.08	22.03

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

19.32

15.64

2.64

13.66

0.15

3.68

14.13

14.3

10.27

2.66

18.6

0.15

4.03

22.08

14.18

10.23

2.57

18.12

0.15

3.94

22.03

Gennex Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Total Revenue Annual	65.6	61.21	59.65
Operating Expenses Annual	60.91	55.84	53.12
Operating Profit Annual	8.65	6.76	6.69
Interest Annual	1.35	0.88	0.74
Depreciation	0.92	0.79	0.88
Net Profit Annual	4.92	3.92	4.04
Tax Annual	1.45	1.17	1.02

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

65.6

60.91

8.65

1.35

0.92

4.92

1.45

61.21

55.84

6.76

0.88

0.79

3.92

1.17

59.65

53.12

6.69

0.74

0.88

4.04

1.02

Gennex Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Cash Flow at the Beginning	8.68	1.07	0.91
Cash Flow from Operations	23.68	11.91	-1.44
Cash Flow from Investing	-38.33	-2.47	-0.02
Cash Flow from Financing	21.03	-1.83	1.62
Cash Flow at the End	15.06	8.68	1.07

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

8.68

23.68

-38.33

21.03

15.06

1.07

11.91

-2.47

-1.83

8.68

0.91

-1.44

-0.02

1.62

1.07

Gennex Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
PBDIT Margin (%)	12.02	10.36	10.49
PBIT Margin (%)	10.74	9.15	9.11
PBT Margin (%)	2.72	-1.24	-3.21
Net PROFIT Margin (%)	6.39	6.01	6.35
Return On Networth / Equity (%)	7.91	9.35	10.67
Return On Networth /Employed(%)	10.17	11.78	13.16
Return On Assets (%)	5.82	7.75	9.2
Total Debt / Equity(X)	0.09	0.21	0.16
Asset Turnover Ratio (%)	0.91	1.29	1.45

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

12.02

10.74

2.72

6.39

7.91

10.17

5.82

0.09

0.91

10.36

9.15

-1.24

6.01

9.35

11.78

7.75

0.21

1.29

10.49

9.11

-3.21

6.35

10.67

13.16

9.2

0.16

1.45

Gennex Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Fixed Assets Annual	82.82	13.7	14.13
Total Current Assets Annual	48.68	47.18	37.67
Non Current Assets Annual	83.63	20.84	21.23
Total Shareholders Funds Annual	80.35	43.82	39.71
Total Assets Annual	132.32	68.03	58.9

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

82.82

48.68

83.63

80.35

132.32

13.7

47.18

20.84

43.82

68.03

14.13

37.67

21.23

39.71

58.9

Gennex Laboratories Ltd Earning Calls

Dec 2023

EPS beaten by 0.00 %

Open Demat Account

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

Get Your FAQs Right

What is Gennex Laboratories Ltd's share capital?

As of May 20, 2024, Gennex Laboratories Ltd has a market capitalization of 99.1 Cr. Value Research classifies it as a Micro-Cap company.

Is Gennex Laboratories Ltd debt-free?

Yes, Gennex Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.22.

What is Gennex Laboratories Ltd's total revenue?

In FY 2023, Gennex Laboratories Ltd recorded a total revenue of approximately 65.6 Cr marking a significant milestone in the company's financial performance.

What is the future growth of Gennex Laboratories Ltd?

Gennex Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.0% annually, respectively..

What is the PE Ratio of Gennex Laboratories Ltd?

Gennex Laboratories Ltd's current PE ratio is 20.14.

What is Gennex Laboratories Ltd's Return on Capital Employed (ROCE)?

Gennex Laboratories Ltd's ROCE averaged 10.4% from the FY ending March 2021 to 2023, with a median of 11.1%. It peaked at 12.3% in March 2021, reflecting strong capital efficiency over the period..

What is the latest EBIT (Earnings Before Interest and Taxes) of Gennex Laboratories Ltd?

Gennex Laboratories Ltd's latest EBIT is Rs. 7.72 Cr, surpassing the average EBIT of Rs. 6.5 Cr over the 5 years..